menu
    • menu

    Company profile for Larimar Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Larimar Therapeutics, based in the Philadelphia area, is committed to discovering and developing treatments for complex rare diseases, with an initial focus on Friedreich’s ataxia. Its proprietary protein replacement therapy platform is intended to deliver missing proteins inside the machinery of cells to treat devastating rare diseases that currently have ineffective or no treatments available.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Larimar TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Three Bala Plaza East Suite 506 Bala Cynwyd, PA 19004
    Telephone
    Telephone
    844-511-9056
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://larimartx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Larimar Therapeutics Reports Third Quarter 2025 Financial Results
    Larimar Therapeutics Reports Third Quarter 2025 Financial Results

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181277/0/en/Larimar-Therapeutics-Reports-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Larimar Therapeutics Updates Nomlabofusp Program
    Larimar Therapeutics Updates Nomlabofusp Program

    29 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/29/3157570/0/en/Larimar-Therapeutics-Announces-Positive-Data-from-Ongoing-Long-term-Open-Label-Study-and-Updates-to-Nomlabofusp-Program-for-Friedreich-s-Ataxia.html

    GLOBENEWSWIRE
    29 Sep 2025
    Share Share
    Larimar Therapeutics Hosts Conference On Nomlabofusp Program
    Larimar Therapeutics Hosts Conference On Nomlabofusp Program

    28 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/28/3157384/0/en/Larimar-Therapeutics-Announces-Conference-Call-on-the-Nomlabofusp-Program-for-the-Treatment-of-Friedreich-s-Ataxia.html

    GLOBENEWSWIRE
    28 Sep 2025
    Share Share
    Larimar Therapeutics Reports Q2 2025 Financial Results
    Larimar Therapeutics Reports Q2 2025 Financial Results

    14 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/14/3133297/0/en/Larimar-Therapeutics-Reports-Second-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    14 Aug 2025
    Share Share
    Larimar Therapeutics Closes Public Offering & Option Exercise
    Larimar Therapeutics Closes Public Offering & Option Exercise

    31 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/31/3125449/0/en/Larimar-Therapeutics-Announces-Closing-of-Underwritten-Public-Offering-of-Common-Stock-and-Exercise-in-Full-of-the-Underwriters-Option-to-Purchase-Additional-Shares.html

    GLOBENEWSWIRE
    31 Jul 2025
    Share Share
    Larimar Therapeutics Proposes Underwritten Public Offering
    Larimar Therapeutics Proposes Underwritten Public Offering

    29 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/29/3123591/0/en/Larimar-Therapeutics-Announces-Proposed-Underwritten-Public-Offering.html

    GLOBENEWSWIRE
    29 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search